{"id":2715,"date":"2022-05-04T06:00:00","date_gmt":"2022-05-04T06:00:00","guid":{"rendered":"https:\/\/www.xvivogroup.com\/us\/mfn_news\/xvivo-has-executed-agreements-with-leading-us-hospitals-and-delivered-the-first-kidney-assist-transport-devices\/"},"modified":"2022-05-04T06:00:00","modified_gmt":"2022-05-04T06:00:00","slug":"xvivo-has-executed-agreements-with-leading-us-hospitals-and-delivered-the-first-kidney-assist-transport-devices","status":"publish","type":"mfn_news","link":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-has-executed-agreements-with-leading-us-hospitals-and-delivered-the-first-kidney-assist-transport-devices\/","title":{"rendered":"XVIVO has executed agreements with leading US hospitals and delivered the first Kidney Assist Transport devices"},"content":{"rendered":"<div class=\"mfn-preamble\">\n<p><strong>XVIVO is pleased to announce that Mayo Clinic in Florida and Northwestern Medicine in Illinois, USA, are the first to receive XVIVO\u2019s Kidney Assist Transport. The device is a transportable organ perfusion system that allows for continuous oxygenated perfusion for up to 24 hours and has been shown to improve preservation compared to cold storage.<\/strong><\/p>\n<\/div>\n<div class=\"mfn-body\">\n<p>Today, the US is the largest kidney transplant market with approximately 18,700 transplants from deceased donors in 2021, and there are currently more than 90,000 patients on the waitlist for a new kidney. Thus, the need for organs available for transplantation far exceeds the supply. By introducing Kidney Assist Transport in the US, XVIVO brings innovation to the kidney market that has the potential to increase the number of kidney transplants significantly.<br \/>An article in the scientific journal The Lancet suggests that hypothermic machine perfusion with oxygen using Kidney Assist Transport can reduce severe complications, additional diagnostic procedures, hospital readmission and cost for chronic dialysis<a href=\"http:\/\/#_ftn1\" target=\"_blank\" rel=\"nofollow noopener\">[1]<\/a>.<\/p>\n<p>The Northwestern Medicine Organ Transplant Center is the largest and most successful transplant program in Illinois, performing 295 kidney transplants in 2021 and nearly 6,500 kidney transplants since its inception in 1964. The team aims to provide transplant options to all patients who suffer from kidney failure, including those who have complex medical issues.<\/p>\n<p>\u201cThis technology will help us enhance the quality of transplanted kidneys, mainly because of continuous oxygenation during perfusion. We expect this to make even more donor kidneys viable for transplantation, which means more patients will receive the life-changing care they need,\u201d says Dr. Daniel Borja-Cacho, transplant surgeon at Northwestern Medicine.<\/p>\n<p>\u201cWe are extremely happy that two of the leading hospitals in the US are first with Kidney Assist Transport. Launching this technology on the world\u2019s largest transplant market is very rewarding as our strategy is to become global leaders within abdominal transplantation. A new era for XVIVO has now begun\u201d says Dag Andersson, CEO of XVIVO.<\/p>\n<p>May 4, 2022<br \/>Gothenburg<br \/>Dag Andersson, CEO<br \/>XVIVO Perfusion AB (publ)<\/p>\n<hr\/>\n<p><a href=\"http:\/\/#_ftnref1\" target=\"_blank\" rel=\"nofollow noopener\">[1]<\/a> Johmanns I, et al. Oxygenated versus standard cold perfusion preservation in kidney transplantation (COMPARE): a randomised, double-blind, paired, phase 3 trial. The Lancet. November 2020;396(10263):1653-1662<\/p>\n<\/div>\n<div class=\"mfn-footer\">\n<p><strong class=\"mfn-heading-1\">For further information, please contact:<\/strong><\/p>\n<hr\/>\n<p>Dag Andersson, CEO, +46 76 643 30 31, e-mail:\u00a0dag.andersson@xvivogroup.com<br \/>Kristoffer\u00a0Nordstr\u00f6m, CFO, +46 73 519 21 64, e-mail:\u00a0kristoffer.nordstrom@xvivogroup.com<\/p>\n<\/div>\n<div class=\"mfn-footer mfn-about\">\n<p><strong class=\"mfn-heading-1\">About Us<\/strong><\/p>\n<hr\/>\n<p>Founded in 1998, XVIVO is the only medical technology company dedicated to extending the life of all major organs &#8211; so transplant teams around the world can save more lives. Our solutions allow leading clinicians and researchers to push the boundaries of transplantation medicine. XVIVO is headquartered in Gothenburg, Sweden, and has offices and research sites on two continents. The company is listed on Nasdaq and has the ticker symbol XVIVO. More information can be found on the website www.xvivogroup.com\/us.<\/p>\n<\/div>\n<div class=\"mfn-footer mfn-attachment mfn-attachment-general\">\n<p><strong class=\"mfn-heading-1\">Attachments<\/strong><\/p>\n<hr\/>\n<p><a class=\"mfn-generated mfn-primary\" href=\"https:\/\/storage.mfn.se\/a798697e-8741-4289-ba37-f62708918fd1\/xvivo-has-executed-agreements-with-leading-us-hospitals-and-delivered-the-first-kidney-assist-transport-devices.pdf\" target=\"_blank\" rel=\"nofollow noopener\">XVIVO has executed agreements with leading US hospitals and delivered the first Kidney Assist Transport devices<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>XVIVO is pleased to announce that Mayo Clinic in Florida and Northwestern Medicine in Illinois, USA, are the first to&#8230;<\/p>\n","protected":false},"template":"","class_list":["post-2715","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci","mfn-news-tag-mfn-ci-other","mfn-news-tag-mfn","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-lang-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>XVIVO has executed agreements with leading US hospitals and delivered the first Kidney Assist Transport devices - XVIVO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-has-executed-agreements-with-leading-us-hospitals-and-delivered-the-first-kidney-assist-transport-devices\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"XVIVO has executed agreements with leading US hospitals and delivered the first Kidney Assist Transport devices - XVIVO\" \/>\n<meta property=\"og:description\" content=\"XVIVO is pleased to announce that Mayo Clinic in Florida and Northwestern Medicine in Illinois, USA, are the first to...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-has-executed-agreements-with-leading-us-hospitals-and-delivered-the-first-kidney-assist-transport-devices\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivo-has-executed-agreements-with-leading-us-hospitals-and-delivered-the-first-kidney-assist-transport-devices\\\/\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivo-has-executed-agreements-with-leading-us-hospitals-and-delivered-the-first-kidney-assist-transport-devices\\\/\",\"name\":\"XVIVO has executed agreements with leading US hospitals and delivered the first Kidney Assist Transport devices - XVIVO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\"},\"datePublished\":\"2022-05-04T06:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivo-has-executed-agreements-with-leading-us-hospitals-and-delivered-the-first-kidney-assist-transport-devices\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivo-has-executed-agreements-with-leading-us-hospitals-and-delivered-the-first-kidney-assist-transport-devices\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivo-has-executed-agreements-with-leading-us-hospitals-and-delivered-the-first-kidney-assist-transport-devices\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"XVIVO has executed agreements with leading US hospitals and delivered the first Kidney Assist Transport devices\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"XVIVO has executed agreements with leading US hospitals and delivered the first Kidney Assist Transport devices - XVIVO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-has-executed-agreements-with-leading-us-hospitals-and-delivered-the-first-kidney-assist-transport-devices\/","og_locale":"en_US","og_type":"article","og_title":"XVIVO has executed agreements with leading US hospitals and delivered the first Kidney Assist Transport devices - XVIVO","og_description":"XVIVO is pleased to announce that Mayo Clinic in Florida and Northwestern Medicine in Illinois, USA, are the first to...","og_url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-has-executed-agreements-with-leading-us-hospitals-and-delivered-the-first-kidney-assist-transport-devices\/","og_site_name":"United States","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-has-executed-agreements-with-leading-us-hospitals-and-delivered-the-first-kidney-assist-transport-devices\/","url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-has-executed-agreements-with-leading-us-hospitals-and-delivered-the-first-kidney-assist-transport-devices\/","name":"XVIVO has executed agreements with leading US hospitals and delivered the first Kidney Assist Transport devices - XVIVO","isPartOf":{"@id":"https:\/\/www.xvivogroup.com\/us\/#website"},"datePublished":"2022-05-04T06:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-has-executed-agreements-with-leading-us-hospitals-and-delivered-the-first-kidney-assist-transport-devices\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-has-executed-agreements-with-leading-us-hospitals-and-delivered-the-first-kidney-assist-transport-devices\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-has-executed-agreements-with-leading-us-hospitals-and-delivered-the-first-kidney-assist-transport-devices\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.xvivogroup.com\/us\/"},{"@type":"ListItem","position":2,"name":"XVIVO has executed agreements with leading US hospitals and delivered the first Kidney Assist Transport devices"}]},{"@type":"WebSite","@id":"https:\/\/www.xvivogroup.com\/us\/#website","url":"https:\/\/www.xvivogroup.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.xvivogroup.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news\/2715","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/media?parent=2715"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}